Effects of hydroxysafflor yellow a in the attenuation of MPTP neurotoxicity in mice

Neurochemical Research

Volumn 35, Issue 1, 2010, Pages 107-113

  Han, B ^a,b   Zhao, H ^a  

^a JILIN UNIVERSITY   (China)

^b YANTAI UNIVERSITY   (China)

Author keywords

1 Methyl 4 phenyl 1,2,3,6 tetrahydropyridine; Hydroxysafflor yellow A; Immunohistochemistry; Parkinson's disease

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; 3,4 DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GLUTATHIONE; HOMOVANILLIC ACID; HYDROXYL RADICAL; HYDROXYSAFFLOR YELLOW A; MALONALDEHYDE; SAFFLOWER EXTRACT; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE BRAIN LEVEL; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; ENZYME ACTIVITY; IMMUNOHISTOCHEMISTRY; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOUSE; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SAFFLOWER; SUBSTANTIA NIGRA;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; CATALASE; CHALCONE; CORPUS STRIATUM; DOPAMINE; GLUTATHIONE; HOMOVANILLIC ACID; IMMUNOHISTOCHEMISTRY; MALE; MALONDIALDEHYDE; MICE; MICE, INBRED C57BL; MPTP POISONING; QUINONES; SUPEROXIDE DISMUTASE;

MUS;

EID: 76849098326     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-009-0035-4     Document Type: Article

References (25)

1. O Hornykiewicz SJ Kish 1987 Biochemical pathophysiology of Parkinson's disease Adv Neurol 45 19 34 1:CAS:528:DyaL2sXhslekur0%3D 2881444
2. LM Sayre G Perry MA Smith 2008 Oxidative stress and neurotoxicity Chem Res Toxicol 21 172 188 10.1021/tx700210j 18052107 (Pubitemid 351219718)
3. JW Langston P Ballard JW Tetrud, et al. 1983 Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 979 980 10.1126/science.6823561 1:STN:280:DyaL3s7hvF2mtg%3D%3D 6823561
4. KF Tipton TP Singer 1993 Advances in our understanding of the mechanisms of the neurotoxicity of MPTP and related compounds J Neurochem 61 1191 1206 10.1111/j.1471-4159.1993.tb13610.x 1:CAS:528:DyaK3sXms1Chsrg%3D 8376979
5. N Schmidt B Ferger 2001 Neurochemical findings in the MPTP model of Parkinson's disease J Neural Transm 108 1263 1282 10.1007/s007020100004 1:CAS:528:DC%2BD38XhsVSqt7g%3D 11768626 (Pubitemid 33141302)
6. C Romano M Price HY Bai, et al. 1993 Neuroprotectants in Honghua: glucose attenuates retinal ischemic damage Invest Ophthalmol Vis Sci 34 72 80 1:STN:280:DyaK3s7ks1yitA%3D%3D 8425843
7. X Wei H Liu X Sun, et al. 2005 Hydroxysafflor yellow A protects rat brains against ischemia-reperfusion injury by antioxidant action Neurosci Lett 386 58 62 10.1016/j.neulet.2005.05.069 1:CAS:528:DC%2BD2MXmsVait7c%3D 16002219 (Pubitemid 41019643)
8. J Tian G Li Z Liu 2008 Hydroxysafflor yellow A inhibits rat brain mitochondrial permeability transition pores by a free radical scavenging action Pharmacology 82 121 126 10.1159/000141653 1:CAS:528:DC%2BD1cXpvFKnu7g%3D 18583922
9. E Sundström A Fredriksson T Archer 1990 Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: a model for Parkinson's disease Brain Res 528 181 188 10.1016/0006-8993(90)91656-2 2271921 (Pubitemid 20318194)
10. M Sedelis K Hofele GW Auburger, et al. 2000 MPTP susceptibility in the mouse: behavioral, neurochemical, and histological analysis of gender and strain differences Behav Genet 30 171 182 10.1023/A:1001958023096 1:STN:280: DC%2BD3M7gvFyhug%3D%3D 11105391 (Pubitemid 30839957)
11. T Araki T Mikami H Tanji, et al. 2001 Biochemical and immunohistological changes in the brain of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated mouse Eur J Pharm Sci 12 231 238 10.1016/S0928-0987(00)00170-6 1:CAS:528:DC%2BD3cXoslGhtLk%3D 11113642
12. JM McCord I Fridovich 1969 Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein) J Biol Chem 244 6049 6055 1:CAS:528:DyaE3cXmsVU%3D 5389100
13. H Aebi 1984 Catalase in vitro Methods Enzymol 105 121 126 10.1016/S0076-6879(84)05016-3 1:CAS:528:DyaL2cXltVKis7s%3D 6727660
14. VH Cohn J Lyle 1966 A fluorimetric assay for glutathione Anal Biochem 14 434 440 10.1016/0003-2697(66)90286-7 1:CAS:528:DyaF28XmvFKisA%3D%3D 5944947
15. H Ohkawa N Ohishi K Yagi 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction Anal Biochem 95 351 358 10.1016/0003-2697(79) 90738-3 1:CAS:528:DyaE1MXksFaisbk%3D 36810 (Pubitemid 9194347)
16. B Thomas D Muralikrishnan KP Mohanakumar 2000 In vivo hydroxyl radical generation in the striatum following systemic administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice Brain Res 852 221 224 10.1016/S0006-8993(99)02202-7 1:CAS:528:DC%2BD3cXnt1Kksw%3D%3D 10661517 (Pubitemid 30017755)
17. OH Lowry NJ Rosebrough AL Farr, et al. 1951 Protein measurement with the Folin phenol reagent J Biol Chem 193 265 275 1:CAS:528:DyaG38XhsVyrsw%3D%3D 14907713
18. M Dhanasekaran CB Albano L Pellet, et al. 2008 Role of lipoamide dehydrogenase and metallothionein on 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity Neurochem Res 33 980 984 10.1007/s11064-007-9468-9 1:CAS:528:DC%2BD1cXks1Ggu7o%3D 17768676
19. GL Willis GA Donnan 1987 Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice Brain Res 402 269 274 10.1016/0006-8993(87)90033-3 1:CAS:528:DyaL2sXhslSntr0%3D 3493826 (Pubitemid 17005295)
20. S Przedborski V Jackson-Lewis 1998 Mechanisms of MPTP toxicity Mov Disord 13 Suppl 1 35 38 9613716
21. D Muralikrishnan M Ebadi HM Brown-Borg 2002 Effect of MPTP on dopamine metabolism in Ames dwarf mice Neurochem Res 27 457 464 10.1023/A:1019888300957 1:CAS:528:DC%2BD38Xmt12rsrc%3D 12199149 (Pubitemid 34894248)
22. D Muralikrishnan KP Mohanakumar 1998 Neuroprotection by bromocriptine against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in mice FASEB J 12 905 912 1:CAS:528:DyaK1cXktlCrsro%3D 9657530
23. J Haavik K Toska 1998 Tyrosine hydroxylase and Parkinson's disease Mol Neurobiol 16 285 309 10.1007/BF02741387 1:CAS:528:DyaK1cXktVSrsbg%3D 9626667
24. FM Hurley DJ Costello AM Sullivan 2004 Neuroprotective effects of delayed administration of growth/differentiation factor-5 in the partial lesion model of Parkinson's disease Exp Neurol 185 281 289 10.1016/j.expneurol.2003.10.003 1:CAS:528:DC%2BD2cXltVGjsQ%3D%3D 14736509 (Pubitemid 38084854)
25. Y Oiwa R Yoshimura K Nakai, et al. 2002 Dopaminergic neuroprotection and regeneration by neurturin assessed by using behavioral, biochemical and histochemical measurements in a model of progressive Parkinson's disease Brain Res 947 271 283 10.1016/S0006-8993(02)02934-7 1:CAS:528:DC%2BD38XmtlCltb8%3D 12176170 (Pubitemid 34899514)